The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756

By afschroeder • September 23, 2025

Rubin SA. The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756. Open Forum Infect Dis. 2025 Aug 21;12(9):ofaf480. doi: 10.1093/ofid/ofaf480. PMID: 40980592; PMCID: PMC12449218.

Tags: Cardiology/Epi, Publications, Veterans Administration

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment of Cardiometabolic Disease

Anker SD, Ji L, Kindel T, Coats AJ, Ojji D, Barragán AP, Rossing P, Zieroth S, Ahmad S, Usman S, Appannah G, Bailey AL, Bennis[...]

The frequency and impact of previous admissions within 90 days of subsequent hospitalization for acute myocarditis: An analysis of the Nationwide readmission database

Afzal A, Qureshi A, Bozkurt B, Fonarow GC, Lip GYH, Kwok CS. The frequency and impact of previous admissions within 90 days of subsequent hospitalization[...]

Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity

Shakil SS, Hsue PY. Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity. Circ Heart Fail. 2026 Mar 11:e014088. doi: 10.1161/CIRCHEARTFAILURE.126.014088. Epub ahead of[...]